McKesson Corporation, a major player in global healthcare services, boasts a market capitalization of $109.1 billion with a vast distribution network. The stock hit a record high of $895.58 before dipping 1.3%, surging nearly 30% in the past three months. Year-to-date, shares have climbed 55.1%. McKesson’s fiscal Q2 results showed a 10.1% increase in revenue to $103.2 billion and a 377% jump in EPS to $8.92. Despite competition, it maintains a “Strong Buy” rating with a mean price target of $936.80, suggesting 6% upside potential.

Read more at Barchart: Is McKesson Corporation Stock Outperforming the S&P 500?